Literature DB >> 7076645

Identification and properties of peptidylarginine deiminase from rabbit skeletal muscle.

K Sugawara, Y Oikawa, T Ouchi.   

Abstract

Peptidylarginine deiminase, which catalyzes the deimination of arginyl residues in protein, was identified and partially purified from rabbit skeletal muscle. The specific activity of the crude extract from the muscle was aboutt 120 times that of the extract from newborn rat epidermis. The enzyme was purified abou 250-fold over the initial extract of rabbit skeletal muscle in a yield of about 53%. The enzyme requires Ca2+ as an essential cofactor and the activity was not inhibited by monoiodoacetate or PCMB. The molecular weight of the enzyme was found to be about 115,000 by gel chromatography on Bio-Gel P-300. The enzyme catalyzed the deimination of arginyl residue when both the alpha-amino and alpha-carboxyl groups were substituted, and showed low activity when substrates had either a free alpha-amino or a free alpha-carboxyl group. The action of the enzyme on free L-arginine was negligible. Proteins such as protamine, histone, and ribonuclease A were better substrates than the other small synthetic peptides tested.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076645     DOI: 10.1093/oxfordjournals.jbchem.a133755

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

2.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I.

Authors:  Marina Guerrin; Akihito Ishigami; Marie-Claire Méchin; Rachida Nachat; Séverine Valmary; Mireille Sebbag; Michel Simon; Tatsuo Senshu; Guy Serre
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.

Authors:  Ted R Mikuls; Geoffrey M Thiele; Kevin D Deane; Jeffrey B Payne; James R O'Dell; Fang Yu; Harlan Sayles; Michael H Weisman; Peter K Gregersen; Jane H Buckner; Richard M Keating; Lezlie A Derber; William H Robinson; V Michael Holers; Jill M Norris
Journal:  Arthritis Rheum       Date:  2012-11

4.  ATP induces protein arginine deiminase 2-dependent citrullination in mast cells through the P2X7 purinergic receptor.

Authors:  Sanja Arandjelovic; Katherine R McKenney; Sunamita S Leming; Kerri A Mowen
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

5.  Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.

Authors:  Gregory J Challener; Jonathan D Jones; Adam J Pelzek; B JoNell Hamilton; Gilles Boire; Artur José de Brum-Fernandes; Ariel Masetto; Nathalie Carrier; Henri A Ménard; Gregg J Silverman; William F C Rigby
Journal:  J Rheumatol       Date:  2015-12-15       Impact factor: 4.666

6.  Citrullination Was Introduced into Animals by Horizontal Gene Transfer from Cyanobacteria.

Authors:  Thomas F M Cummings; Kevin Gori; Luis Sanchez-Pulido; Gavriil Gavriilidis; David Moi; Abigail R Wilson; Elizabeth Murchison; Christophe Dessimoz; Chris P Ponting; Maria A Christophorou
Journal:  Mol Biol Evol       Date:  2022-02-03       Impact factor: 16.240

7.  Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.

Authors:  Anne-Marie Quirke; Elena Birgitta Lugli; Natalia Wegner; Bart C Hamilton; Peter Charles; Muslima Chowdhury; A Jimmy Ytterberg; Roman A Zubarev; Jan Potempa; Shauna Culshaw; Yonghua Guo; Benjamin A Fisher; Geoffrey Thiele; Ted R Mikuls; Patrick Jw Venables
Journal:  Ann Rheum Dis       Date:  2013-03-05       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.